Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum]
Restelli U, Ceresoli GL, Croce D et al. Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study. Cancer Management and Research. 2017;9:789–800.On page 796, above the Disclosure section, the Acknowledgment section is missing. The...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-03-01
|
| Series: | Cancer Management and Research |
| Online Access: | https://www.dovepress.com/corrigendum-economic-burden-of-the-management-of-metastatic-castr-peer-reviewed-article-CMAR |
| Summary: | Restelli U, Ceresoli GL, Croce D et al. Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study. Cancer Management and Research. 2017;9:789–800.On page 796, above the Disclosure section, the Acknowledgment section is missing. The missing text is:AcknowledgmentThe authors thank Ray Hill, an independent medical writer, who provided English-language editing and journal styling prior to submission on behalf of Health Publishing & Services Srl. Editorial support was funded through an unconditional contribution by Bayer SpA.Read the original article. |
|---|---|
| ISSN: | 1179-1322 |